| Spherocytic anaemia | Blood and lymphatic system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Splenomegaly | Blood and lymphatic system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Mitral valve prolapse | Cardiac disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Sinus tachycardia | Cardiac disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Goitre | Endocrine disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Iridocyclitis | Eye disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Abdominal adhesions | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0004 affected1,432 at risk
- EG0014 affected1,452 at risk
- EG0024 affected1,452 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Crohn's disease | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Gastrointestinal disorder | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Impaired gastric emptying | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Irritable bowel syndrome | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Odynophagia | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Salivary gland calculus | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Umbilical hernia | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Abdominal hernia | Gastrointestinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Chest pain | General disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Pyrexia | General disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Device dislocation | General disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Cholecystitis | Hepatobiliary disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0002 affected1,432 at risk
- EG0012 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Cholecystitis chronic | Hepatobiliary disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Cholelithiasis | Hepatobiliary disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0012 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Gallbladder polyp | Hepatobiliary disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Anaphylactic reaction | Immune system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Drug hypersensitivity | Immune system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Appendicitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0006 affected1,432 at risk
- EG0017 affected1,452 at risk
- EG0028 affected1,452 at risk
|
| Campylobacter gastroenteritis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Cellulitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Cystitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Diverticulitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Genital herpes | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Infection | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Influenza | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Meningitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Meningitis viral | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Pelvic inflammatory disease | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0002 affected1,432 at risk
- EG0014 affected1,452 at risk
- EG0025 affected1,452 at risk
|
| Peritoneal abscess | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Peritonitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Peritonsillar abscess | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Pneumonia | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0002 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Pyelonephritis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Pyelonephritis acute | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Sinusitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Tonsillitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0002 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Vestibular neuronitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Viral infection | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Streptococcal sepsis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Tubo-ovarian abscess | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Enterocolitis infectious | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Herpes dermatitis | Infections and infestations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Ankle fracture | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Foot fracture | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Forearm fracture | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Ligament sprain | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Multiple injuries | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Subdural haematoma | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Uterine perforation | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Thermal burn | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Pelvic fracture | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Procedural pain | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0012 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Meniscus injury | Injury, poisoning and procedural complications | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Haemoglobin decreased | Investigations | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Weight increased | Investigations | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Loose body in joint | Musculoskeletal and connective tissue disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Synovitis | Musculoskeletal and connective tissue disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Axillary mass | Musculoskeletal and connective tissue disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Intervertebral disc protrusion | Musculoskeletal and connective tissue disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Joint instability | Musculoskeletal and connective tissue disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Acute leukaemia | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Ovarian germ cell teratoma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (16.0) | Non-systematic Assessment | | - EG0002 affected1,432 at risk
- EG0012 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Pancreatic carcinoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Uterine leiomyoma | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Teratoma benign | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Cervix carcinoma stage 0 | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Astrocytoma, low grade | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Thyroid cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (16.0) | Non-systematic Assessment | | - EG0002 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Convulsion | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Dizziness | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0012 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Headache | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Migraine | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Multiple sclerosis | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Sciatica | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Trigeminal neuralgia | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Status migrainosus | Nervous system disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Abortion missed | Pregnancy, puerperium and perinatal conditions | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Abortion spontaneous | Pregnancy, puerperium and perinatal conditions | MedDRA (16.0) | Non-systematic Assessment | | - EG0003 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Blighted ovum | Pregnancy, puerperium and perinatal conditions | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Ectopic pregnancy | Pregnancy, puerperium and perinatal conditions | MedDRA (16.0) | Non-systematic Assessment | | - EG0003 affected1,432 at risk
- EG0016 affected1,452 at risk
- EG0027 affected1,452 at risk
|
| Premature separation of placenta | Pregnancy, puerperium and perinatal conditions | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Ruptured ectopic pregnancy | Pregnancy, puerperium and perinatal conditions | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Abortion spontaneous incomplete | Pregnancy, puerperium and perinatal conditions | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Affective disorder | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Alcoholism | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Anxiety | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Completed suicide | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Depression | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0023 affected1,452 at risk
|
| Depression suicidal | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Drug dependence | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Hallucination, auditory | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Panic reaction | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Suicide attempt | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Polysubstance dependence | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Bipolar disorder | Psychiatric disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Strangury | Renal and urinary disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Stress urinary incontinence | Renal and urinary disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Endometriosis | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Ovarian cyst | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0012 affected1,452 at risk
- EG0022 affected1,452 at risk
|
| Ovarian cyst ruptured | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Pelvic adhesions | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Uterine prolapse | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Uterine spasm | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Ovarian cyst torsion | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Haemorrhagic ovarian cyst | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0002 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Vaginal perforation | Reproductive system and breast disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Asthma | Respiratory, thoracic and mediastinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Erythema multiforme | Skin and subcutaneous tissue disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Detoxification | Surgical and medical procedures | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0011 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Hypertension | Vascular disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Varicose vein | Vascular disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0000 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0021 affected1,452 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA (16.0) | Non-systematic Assessment | | - EG0001 affected1,432 at risk
- EG0010 affected1,452 at risk
- EG0020 affected1,452 at risk
|